Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
July 8th, 2020
This paper reports that the addition of Y-27632 to TIVA medium can significantly increase the yield of melanocytes from adult skin tissues.
The general goal of the cells based protocol is to isolate and culture human melanocytes cells, improving the shortcomings of conventional methods. From the new method we can get larger amounts of primary melanocytes cells in a relatively short time, based on materials and equipments. Human tissues used in this protocol are fresh adult for skin tissues discarded from circumcision surgery at the hospital and handled according to the guidelines of the Institution's Human Research Ethics Committee number 2015120401, date May 12 2015.
This is a display of all required reagents. Prepare sterile instruments and materials in advance and set the tissue into a dish, wash the tissue with 75%ethanol for 30 seconds and with washes solution ties five minutes each cuts the tissue into convenient pieces and scrap the tissue with surgical blade to remove the fat layer. Flatten the tissues with the dermis side down add 2.5 milligram per milliliter the space solution to the skin tissues.
Cover and store the pieces at four degrees centigrade overnight. On the second day, peel off the epidermis from the dermis and immediately transfer the epidermis into another three dishes with washing solution in turn submerges 0.05%trypsin in the tube incubated for 30 minutes in a water bath at 37 degrees centigrade. Add an equal volume of the neutralization solution.
Pipettes the solution up and down for 10 to 15 times. Pass the solution through a 100 micrometer mash filter. centrifuge at 200 times g for five minutes remove the supernatant re-suspend the cell pallet in 10 milliliter of tiva medium.
Add 10 micrometer of Y-27632. Mark the information this is the field of view under the microscope. It shows cells floating in the medium incubate in a 37 degrees centigrade incubator.
This view shows the view on day two the cells have started to attach the bottom of the dish. And the view on day nine shows obvious deposits of melanocytes exist. Remove the supernatant wash the cells with PBS add two millimeter of 0.05%trypsin incubate the cells for two minutes add two milliliter of the neutralization solution.
centrifuge at 200 times g for five minutes. Remove the supernatant slowly re-suspend the cell pallet with 10 millimeter of tiva medium. Change the medium every two days.
These pictures show the views of passage one schematic diagram so the new method and the conventional method are presented in this figure. The procedure for tissue preparation and the digestion of new method is the same as the conventional method. The only difference is that the isolated fat cells inoculated in 10 minute in her tiva medium with the presence of 10 micrometer Y-27632.
After two days replace the media with tiva medium without supplements at Y-27632. This panel shows representative images of melanocytes prepared by the conventional method top row and by the new method bottom row at day three, day six and day eight after the initial inoculation we call the number of melanocytes at day three, day six and eight, we found that the new method increased the melanocytes yield by about five times. After eight days counter we did dozen and count the number of melanocytes in each single dish.
The results showed that the number of melanocytes isolated by new method is much more than the conventional method. Ki67 standing confirm that melanocytes isolated by new method can normally proliferate more importantly we obtained normal function of melanocytes with the new method. We checked the purity of melanocytes after initial passage from the isolation.
The passage one melanocytes for stand for MITF expression which expressed only in melanocytes. And we found nearly 100%cells were positive for MITF indicating pure melanocytes obtained after first passage. To test melanocytes isolated from the new methods can function normally.
We treated melanocytes with force cooling for over 90 in vitro and observe that force cooling can induce the pigmentation of melanocytes. Taking these data together suggests that the melanocytes isolated from the new method can normally produce pigmentation. Primary melanocytes, as stated above skin and extended in culture have been readily used for laboratory research and the clinical applications.
Having reported that ID Y-27632 into the initial culture medium before two days can dramatically increases the out of melanocytes. In summary, we successfully established a new simple and highly efficient method to isolate pure primary melanocytes from adult tissues.
View the full transcript and gain access to thousands of scientific videos
Overview
This study explores a new method for isolating and culturing human melanocytes from adult skin tissues, specifically enhancing the yield compared to traditional techniques. The addition of Y-27632 to the culture medium was found to significantly increase the number of melanocytes obtained within a short time frame.
Key Study Components
Research Area
- Cell biology
- Melanocyte culture
- Improvement of isolation techniques
Background
- Standard methods have limitations in melanocyte yield.
- Fresh adult skin tissues were sourced from circumcision surgeries.
- Research adheres to ethical guidelines.
Methods Used
- Isolation and culture protocol for primary melanocytes
- Human tissues from adult skin
- Use of TIVA medium and Y-27632
Main Results
- The new method increased melanocyte yield by five times compared to conventional methods.
- Melanocytes showed normal growth and functionality, including normal pigmentation responses.
- Purity of isolated melanocytes was nearly 100% as confirmed by MITF expression.
Conclusions
- This research establishes a simple and efficient method for obtaining pure primary melanocytes.
- The findings enhance the potential for laboratory research and clinical applications regarding skin biology.
Frequently Asked Questions
Executive Industry Relevance
Efficient isolation of primary human melanocytes from adult skin tissues addresses a critical bottleneck in pigmentation and melanoma research. The Y-27632-enhanced protocol improves yield and reduces culture time, enabling faster access to biologically relevant cells for target validation and assay development. This advancement supports preclinical modeling of skin disorders and therapeutic screening using readily available clinical tissue sources.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of melanocyte-specific pathways and therapeutic target validation using pure primary cells from adult tissues.
- Operational Value: Reduces culture time from weeks to days, accelerating hypothesis testing and target de-risking in early discovery.
Screening & Assay Development
- Scientific Value: Provides a reproducible, high-yield source of functional melanocytes for standardized assay development and compound screening.
- Operational Value: Increases throughput and scalability of melanocyte-based assays by improving cell yield approximately fivefold over conventional methods.
Translational & Preclinical Research
- Scientific Value: Supports disease-relevant modeling of pigmentation defects and melanoma using primary melanocytes with confirmed MITF purity and normal pigmentation response.
- Operational Value: Ensures translational continuity from isolation to functional validation, reducing variability in preclinical efficacy and safety assessments.
Pipeline & Workflow Integration
The method fits within the discovery continuum by enabling reliable production of primary melanocytes for downstream applications in target validation, screening, and preclinical evaluation.
- Discovery Biology: Supports hypothesis testing and pathway clarification through access to pure, functional melanocytes from adult skin.
- Screening: Enhances assay readiness and reproducibility by delivering a standardized, high-purity cell source suitable for compound evaluation.
- Analytics: Enables quantitative assessment of melanocyte proliferation, differentiation, and pigmentation as key phenotypic readouts.
- Translational Research: Connects isolation to preclinical continuity via validated MITF expression and normal functional response to pigmentation stimuli.
- Enterprise Reuse: Establishes a reusable platform for melanocyte production that can be integrated across multiple projects in dermatology and oncology.
Operational & Enterprise Impact
- Scientific Value: Improves predictive confidence by providing melanocytes with near-homogeneous purity and validated physiological function.
- Operational Value: Increases standardization and scalability of melanocyte isolation, reducing batch-to-batch variability in research workflows.
- Strategic Value: Supports better go/no-go decisions by reducing biological ambiguity in target validation and assay performance.
- Portfolio Impact: Enables risk-adjusted prioritization of melanoma and pigmentation programs through reliable access to clinically relevant primary cells.
Implementation Considerations
- Requires expertise in primary cell culture and tissue handling under ethical guidelines for human skin samples.
- Depends on access to sterile instruments, TIVA medium, trypsin neutralization, and Y-27632 at 10 micromolar concentration.
- Necessitates standardized protocols for tissue processing, including overnight cold storage and enzymatic digestion steps.
- Involves adaptation considerations when applying the protocol to different adult skin donors or anatomical sites.
- Limited by the need for functional validation (e.g., MITF staining, pigmentation assays) to confirm purity and physiological relevance.
